Barriers to ART adherence & follow ups among patients attending ART centres in Maharashtra, India

Indian Journal of Medical Research

Volumn 134, Issue 12, 2011, Pages 954-959

  Joglekar, N ^a   Paranjape, R ^a   Jain, R ^b   Rahane, G ^a   Potdar, R ^a   Reddy, K S ^a   Sahay, Seema ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b National AIDS Control Organization (NACO)   (India)

Author keywords

ART adherence; Barriers; Beliefs; Counselling; Financial barriers; India; Service delivery; Stigma

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CULTURAL FACTOR; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HEALTH BELIEF; HUMAN; INDIA; INTERVIEW; MALE; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; RITUAL; SOCIOECONOMICS; STIGMA; TIME; UNEMPLOYMENT;

EID: 84856582463     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-5916.92642     Document Type: Article

References (24)

1. Department of AIDS Control, Ministry of Health and Family Welfare, Annual report 2009-2010. Available from: http://www.nacoonline.org/upload/AR%202009-10/NACO_AR_English%20corrected.pdf, accessed on August 13, 2011.
2. National AIDS Control programme III, National AIDS Control Organization, Ministry of Health and Family Welfare (2006). Goals and objectives. Available from: http://www.nacoonline. org/National_AIDS_Control_Program/, accessed on June 8, 2010.
3. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: A systematic review. PLoS Med 2007; 4 (10): e298.
4. Operational Guidelines for Link ART Centers. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India. 2008. Available from: http://nacoonline. org/Divisions/CST/Link_ART_Centers/, accessed on June 13, 2010.
5. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squire C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
6. Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. Ministry of Health and Family Welfare, Department of AIDS Control, May 2007. Available from: http://www.nacoonline.org/, accessed on September 30, 2011.
7. Wang X, Yang L, Li H, Zuo L, Liang S, Liu W, et al. Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China. Curr HIV Res 2011; 92: 103-11.
8. El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One 2011; 6: e17518.
9. Patel A, Hirschhorn L, Fullem A, Ojikutu B, Oser R. Adult aherence to treatment and retention in care. Arlington, VA: USAID{pipe} AIDSTAR-ONE PROJECT, Task Order 1. 2010.
10. CMIS Bulletin, (April 2008 to Sept 2008). National AIDS Control Organization, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India. Available from: http://www.nacoonline.org/upload/Care%20&%20 Treatment/functional%20LAC%20centers%20July%202010. pdf, accessed on April 13, 2011.
11. Sogarwal R, Bachani D. Assessment of-ART centers in India: client perspectives. J Indian Med Assoc 2009; 107: 276-80.
12. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3: e438.
13. Chaturvedi S, Arora N K, Dasgupta R, Patwari AK. Are we reluctant to talk about cultural determinants? Indian J Med Res 2011; 133: 361-3.
14. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J 2008; 5: 136-43.
15. Curioso WH, Kepka D, Cabello R, Segura P, Kurth AE. Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study. BMC Public Health 2010; 10: 13.
16. Sankar A, Golin C, Simoni JM, Luborsky M, Pearson C. How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1): S54-68.
17. Sahay S, Ghate M, Mehendale S. Managing HIV Therapy literacy in resource-limited settings. HIV Ther 2009; 3: 339-44.
18. Strauss A, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park, California: Sage; 1990.
19. Singh JP. Problems of India's changing family and state intervention. Available from: http://www.un.org/esa/socdev/family/docs/egm09/Singh.pdf, accessed on April 29, 2011.
20. Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health 2008; 8: 63.
21. Pandikumar P, Chellappandian M, Mutheeswaran S, Ignacimuthu S. Consensus of local knowledge on medicinal plants among traditional healers in Mayiladumparai block of Theni District, Tamil Nadu, India. J Ethnopharmacol 2011; 134: 354-62.
22. Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AK, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDs 2005; 19: 526-37.
23. Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1): S127-33.
24. Reynolds SJ, Bartlett JG, Quinn TC, Beyrer C, Bollinger RC. Antiretroviral therapy where resources are limited. N Engl J Med 2003; 348:1806-9.